119 related articles for article (PubMed ID: 20662667)
1. Hydroxyapatite as a carrier for bone morphogenetic protein.
Rohanizadeh R; Chung K
J Oral Implantol; 2011 Dec; 37(6):659-72. PubMed ID: 20662667
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of hydroxyapatite with different crystallinity: effects on protein adsorption and release.
Lee WH; Zavgorodniy AV; Loo CY; Rohanizadeh R
J Biomed Mater Res A; 2012 Jun; 100(6):1539-49. PubMed ID: 22419559
[TBL] [Abstract][Full Text] [Related]
3. Characterization of dicalcium phosphate dihydrate cements prepared using a novel hydroxyapatite-based formulation.
Alge DL; Santa Cruz G; Goebel WS; Chu TM
Biomed Mater; 2009 Apr; 4(2):025016. PubMed ID: 19349655
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface.
Bae SE; Choi J; Joung YK; Park K; Han DK
J Control Release; 2012 Jun; 160(3):676-84. PubMed ID: 22543042
[TBL] [Abstract][Full Text] [Related]
5. BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate.
Tazaki J; Murata M; Akazawa T; Yamamoto M; Ito K; Arisue M; Shibata T; Tabata Y
Biomed Mater Eng; 2009; 19(2-3):141-6. PubMed ID: 19581707
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2.
Hannink G; Geutjes PJ; Daamen WF; Buma P
J Mater Sci Mater Med; 2013 Feb; 24(2):325-32. PubMed ID: 23135410
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on in vitro biocompatibility of synthetic octacalcium phosphate and calcium phosphate ceramics used clinically.
Morimoto S; Anada T; Honda Y; Suzuki O
Biomed Mater; 2012 Aug; 7(4):045020. PubMed ID: 22740587
[TBL] [Abstract][Full Text] [Related]
8. Hollow calcium phosphate microcarriers for bone regeneration: in vitro osteoproduction and ex vivo mechanical assessment.
Santoni BG; Pluhar GE; Motta T; Wheeler DL
Biomed Mater Eng; 2007; 17(5):277-89. PubMed ID: 17851170
[TBL] [Abstract][Full Text] [Related]
9. Theoretical analysis of calcium phosphate precipitation in simulated body fluid.
Lu X; Leng Y
Biomaterials; 2005 Apr; 26(10):1097-108. PubMed ID: 15451629
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of spherical Ca-deficient hydroxyapatite granules with controlled surface microstructure as drug carriers.
Kamitakahara M; Imai R; Ioku K
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):2446-50. PubMed ID: 23498281
[TBL] [Abstract][Full Text] [Related]
11. The effect of the delivery carrier on the quality of bone formed via bone morphogenetic protein-2.
La WG; Kwon SH; Lee TJ; Yang HS; Park J; Kim BS
Artif Organs; 2012 Jul; 36(7):642-7. PubMed ID: 22372949
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
Zhu M; Zeng Y; Sun T; Peng Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
[TBL] [Abstract][Full Text] [Related]
13. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Fu YC; Nie H; Ho ML; Wang CK; Wang CH
Biotechnol Bioeng; 2008 Mar; 99(4):996-1006. PubMed ID: 17879301
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect.
Rojbani H; Nyan M; Ohya K; Kasugai S
J Biomed Mater Res A; 2011 Sep; 98(4):488-98. PubMed ID: 21681941
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
[TBL] [Abstract][Full Text] [Related]
17. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
[TBL] [Abstract][Full Text] [Related]
18. Bone regeneration using a naturally grown HA/TCP carrier loaded with rh BMP-2 is independent of barrier-membrane effects.
Schopper C; Moser D; Spassova E; Goriwoda W; Lagogiannis G; Hoering B; Ewers R; Redl H
J Biomed Mater Res A; 2008 Jun; 85(4):954-63. PubMed ID: 17896771
[TBL] [Abstract][Full Text] [Related]
19. Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.
Ono I; Yamashita T; Jin HY; Ito Y; Hamada H; Akasaka Y; Nakasu M; Ogawa T; Jimbow K
Biomaterials; 2004 Aug; 25(19):4709-18. PubMed ID: 15120517
[TBL] [Abstract][Full Text] [Related]
20. Tetracalcium phosphate: Synthesis, properties and biomedical applications.
Moseke C; Gbureck U
Acta Biomater; 2010 Oct; 6(10):3815-23. PubMed ID: 20438869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
